There is evidence that the SASP-mediated inflammatory response enhances immune control of senescent tumorous lesions in colorectal carcinoma and prevents malignant transformation in the presence of functional p53 but is protumorigenic in p21/p53-deficient lesions (74). This evidence concerns the gene TP53 and colorectal carcinoma.